Latest Drug Approvals news
FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis
posted October 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Zoryve for Atopic Dermatitis in Young Children
posted October 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Tremfya for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis
posted October 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Inluriyo for Advanced Breast Cancer
posted September 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
